Search for Clinical Trial Results

Sponsored By

Leukemia, Myelomonocytic, Acute - 3 Studies Found

Status Study
Completed Study Name: Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML
Condition: Leukemia, Myelomonocytic, Acute
Date: 2006-08-10
Interventions: Drug: XIAP antisense 2 days loading dose followed by weekly 2hr infusion
Completed Study Name: Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia
Condition: Leukemia, Myelomonocytic, Acute
Date: 2010-07-30
Interventions: Drug: Erlotinib Erlotinib will be administered orally at 150 mg once a day, continuously. Each cycle wil
Active, not recruiting Study Name: A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib
Condition: Myelomonocytic Leukemia
Date: 2013-01-24
Interventions: Drug: Ruxolitinib In Phase I, participants will be allocated to twice a day (BID) doses of 10 mg/d up to